THE ORIGINAL CONVENIENT PREFILLED, NO-MIX SYRINGE FOR GnRH TREATMENT OF ADVANCED PROSTATE CANCER IN ADULTS
CAMCEVI® is still the first and only sub-Q leuprolide therapy in a prefilled, no-mix, ready-to-inject formulation that simplifies GnRH agonist preparation—offering consistent testosterone suppression, after the initial injection, to castrate levels from Week 4 to Week 48.1
Don’t sweat syringe prep1
PROVEN
LEUPROLIDE EFFICACY
CAMCEVI offers proven leuprolide efficacy in a convenient prefilled, no-mix syringe.1

SIMPLIFIED
PREPARATION
CAMCEVI comes prefilled with no mixing required—simplifying syringe prep for you.1

DON’T SWEAT
THE J CODE
Permanent J Code J1952 is unique to CAMCEVI and unaffected by market price changes.
Don’t sweat
the coverage2,3
*As of 12/06/23.
Coverage is not indicative of
utilization management criteria.
96%
patients covered by
Medicare*
91%
patients covered by
Commercial*
*As of 12/06/23.
Coverage is not indicative of
utilization management criteria.

LIVES AND GROWING*
Patients who have undergone treatment on CAMCEVI4
*As of 08/31/2023.